Retrospective evaluation of pregabalin for cancer-related neuropathic pain

Japanese Journal of Anesthesiology

Volumn 61, Issue 2, 2012, Pages 147-154

  Baba, Mika ^a   Gomyo, Ikuo ^a  

^a Saito Yukoukai Hospital   (Japan)

Author keywords

Cancer pain; Neuropathic pain; Palliative care; Pregabalin

Indexed keywords

PREGABALIN;

AGE DISTRIBUTION; ARTICLE; CANCER PAIN; CANCER PATIENT; DISEASE SEVERITY; DRUG DOSE COMPARISON; HOSPITAL PATIENT; HUMAN; NEUROPATHIC PAIN; RETROSPECTIVE STUDY; SOMNOLENCE;

AGED; ANALGESICS; DISORDERS OF EXCESSIVE SOMNOLENCE; FEMALE; GAMMA-AMINOBUTYRIC ACID; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; NEURALGIA; PALLIATIVE CARE; RETROSPECTIVE STUDIES;

EID: 84857409675     PISSN: 00214892     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Caraceni A, Zecca E, Bonezzi C, Arcuri E, Tur RY, Maltoni M, et al. Gabapentin for neuropathic cancer pain: A randomized controlled trial from the Gabapentin Cancer Pain Study Group. J Clin Oncol 2004; 22: 2909-17. (Pubitemid 41079911)
2. Dworkin RH, O'Connor AB, Backonja M, Farrar JT, Finnerup NB, Jensen TS, et al. Pharmacologic management of neuropathic pain: Evidence-based recommendations. Pain 2007; 132: 237-51. (Pubitemid 350051570)
3. Stubblefield MD, Burstein HJ, Burton AW, Custodio CM, Deng GE, Ho M, et al. NCCN task force report: Management of neuropathy in cancer. J Natl Compr Canc Netw 2009; 7: S1-26.
4. Pourzitaki C, Logotheti H, Sardeli C, Papazisis G, Arampatzis P, Kouvelas D. Pregabalin combined with epidural analgesia in chronic cancer pain patients. Review of clinical pharmacology and pharmacokinetics international edition 2008; 22: 308-9.
5. Vondracek P, Oslejskova H, Kepak T, Mazanek P, Sterba J, Rysava M, et al. Efficacy of pregabalin in neuropathic pain in paediatric oncological patients. Eur J Paediatr Neurol 2009; 13: 332-6.
6. Bouhassira D, Attal N. Diagnosis and assessment of neuropathic pain: The saga of clinical tools. Pain 2011; 152: S74-83.
7. Toth C. Substitution of gabapentin therapy with pregabalin therapy in neuropathic pain due to peripheral neuropathy. Pain Med 2010; 11: 456-65.
8. O'Connor AB, Dworkin RH. Treatment of neuropathic pain: An overview of recent guidelines. Am J Med 2009; 122: S22-32.
9. Freynhagen R, Strojek K, Griesing T, Whalen E, Balkenohl M. Efficacy of pregabalin in neuropathic pain evaluated in a 12-week, randomised, double-blind, multicentre, placebo-controlled trial of flexible- and fixed-dose regimens. Pain 2005; 115: 254-63. (Pubitemid 40725282)
10. Bockbrader HN, Radulovic LL, Posvar EL, Strand JC, Alvey CW, Busch JA, et al. Clinical pharmacokinetics of pregabalin in healthy volunteers. J Clin Pharmacol 2010; 50: 941-50.
11. Bockbrader HN, Wesche D, Miller R, Chapel S, Janiczek N, Burger P. A comparison of the pharmacokinetics and pharmacodynamics of pregabalin and gabapentin. Clin Pharmacokinet 2010; 49: 661-9.
12. Perucca E. Pharmacokinetic variability of new antiepileptic drugs at different ages. Ther Drug Monit 2005; 27: 714-7. (Pubitemid 44391721)
13. Sabatowski R, Gálvez R, Cherry DA, Jacquot F, Vincent E, Maisonobe P, et al. Pregabalin reduces pain and improves sleep and mood disturbances in patients with post-herpetic neuralgia: Results of a randomised, placebo-controlled clinical trial. Pain 2004; 109: 26-35. (Pubitemid 38479767)
14. Rosenstock J, Tuchman M, LaMoreaux L, Sharma U. Pregabalin for the treatment of painful diabetic peripheral neuropathy: A double-blind, placebo-controlled trial. Pain 2004; 110: 628-38. (Pubitemid 39036794)
15. Zin CS, Nissen LM, O'Callaghan JP, Duffull SB, Smith MT, Moore BJ. A randomized, controlled trial of oxycodone versus placebo in patients with postherpetic neuralgia and painful diabetic neuropathy treated with pregabalin. J Pain 2010; 11: 462-71.